<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Geneviève Waeterloos</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Production et accès aux produits médicaux (Vaccin): Témoignage Sciensano: renforcement  (RFDA)</style></title><secondary-title><style face="normal" font="default" size="100%">Evénement bi-annuel de networking:  La valeur ajoutée de l’expertise publique belge pour la coopération internationale</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">capacity-building</style></keyword><keyword><style  face="normal" font="default" size="100%">libération de lot</style></keyword><keyword><style  face="normal" font="default" size="100%">vaccin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2024/09/02</style></date></pub-dates></dates><publisher><style face="normal" font="default" size="100%">ENABEL</style></publisher><pub-location><style face="normal" font="default" size="100%">Brussels, Belgium</style></pub-location><issue><style face="normal" font="default" size="100%">ENABEL</style></issue></record></records></xml>